Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: A double-blind controlled pilot study
MetadataShow full item record
Objective: This study evaluated the augmentation of venlafaxine with hormone therapy in the treatment of postmenopausal depression. The hormones evaluated were estrogen (0.625 mg) in combination with medroxyprogesterone acetate (2.5 mg) and methyltestosterone (2.5 mg). Design: Seventy-two menopausal women (mean age: 53.6 ± 4.27 years) diagnosed with depression (Montgomery-Åsberg Depression Rating Scale [MADRS] scores ≥ 20) were treated with venlafaxine and one of the following hormone therapy combinations, in a double-blind regimen: estrogen + medroxyprogesterone + methyltestosterone (group 1, n = 20); estrogen + medroxyprogesterone acetate (group 2, n = 20); methyltestosterone only (group 3, n = 16); and no hormone therapy (group 4, n = 16). Study duration was 24 weeks. Primary efficacy outcome was remission according to the MADRS, whereas secondary efficacy measures included the Clinical Global Impression (CGI), Blatt-Kupperman Index, and Women's Health Questionnaire (WHQ). Results: Forty-eight patients completed the study. All groups showed significant improvement from baseline. Group 3 demonstrated significant improvement on the MADRS compared with placebo (group 4) at weeks 20 (P = 0.048) and 24 (P = 0.030); effect size 8.04 (0.83; 15.26) (P = 0.029), but also had the highest dropout rate. Groups 1 and 3 had significant CGI improvement rates compared with placebo: 42.23% (P = 0.012) and 44.45% (P = 0.08), respectively. There were no differences in the WHQ or BKI scores among the groups. Conclusions: Methyltestosterone 2.5 mg had the highest effect size compared with placebo, but the high dropout rate prevented its efficacy from being determined. Estrogen plus medroxyprogesterone, combined with methyltestosterone or otherwise, demonstrated a trend toward increased efficacy of venlafaxine. Further larger-scale clinical trials are needed to elucidate the findings of this pilot study. © 2006 by The North American Menopause Society.
How to cite this document
Showing items related by title, author, creator and subject.
Dental students' familiarity with the medical management of dental patients at Brazilian dental schools Araújo, Paula Caetano; Garbin, Clea Adas Saliba ; Moimaz, Suzely Adas Saliba ; Saliba, Nemre Adas ; Arcieri, Renato Moreira (Journal of Dental Education, 2013) [Artigo]Drug therapy in dentistry is essential for patients' treatment and requires special care by dentists, so it must be part of a well-grounded education for predoctoral dental students. The aim of this study was to evaluate ...
Adjunctive antimicrobial photodynamic treatment of experimentally induced periodontitis in rats with ovariectomy Garcia, Valdir Gouveia ; Gualberto Júnior, Erivan Clementino ; Fernandes, Leandro Araújo; Bosco, Álvaro Francisco ; Nagata, Maria José Hitomi ; Casatti, Cláudio Aparecido ; Ervolino, Edilson ; Theodoro, Letícia Helena (Journal of Periodontology, 2013) [Artigo]Background: The aim of this study is to compare antimicrobial photodynamic therapy (aPDT) as an adjunctive therapy to scaling and root planing (SRP) for the treatment of experimentally induced periodontitis in rats with ...
De Abreu Venancio, R. ; Camparis, Cinara Maria ; De Fátima Zanirato Lizarelli, R. (Journal of Oral Rehabilitation, 2005) [Artigo]This study aimed to evaluate the effectiveness of low intensity laser therapy (LILT) in 30 patients presenting temporomandibular joint (TMJ) pain and mandibular dysfunction in a random and double-blind research design. The ...